Profile
Thierry Bertrand Lambert currently works at Berkem SA, as Independent Director from 2021.
Mr. Lambert also formerly worked at Naturex SA, as Chief Financial & Administrative Officer from 2014 to 2015, Safe SA (France), as Chief Financial Officer from 2015 to 2017, and Theranexus SA, as Chief Financial & Administrative Officer from 2017 to 2024.
Mr. Lambert received his Masters Business Admin degree from INSEAD and undergraduate degree from the University of Birmingham.
Thierry Bertrand Lambert active positions
| Companies | Position | Start |
|---|---|---|
| GROUPE BERKEM | Director/Board Member | 2021-03-07 |
Former positions of Thierry Bertrand Lambert
| Companies | Position | End |
|---|---|---|
| THX PHARMA | Director of Finance/CFO | 2024-03-31 |
| SAFE S.A. | Director of Finance/CFO | 2017-11-08 |
| NATUREX | Director of Finance/CFO | 2015-03-30 |
Training of Thierry Bertrand Lambert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Naturex SA
Naturex SA Chemicals: SpecialtyProcess Industries Manufactures essential oils | Process Industries |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berkem SA
Berkem SA Chemicals: SpecialtyProcess Industries Operates as a holding company whose subsidiaries engages in construction materials, health beauty nutrition, hygiene protection and industry products | Process Industries |
Safe SA (France)
Safe SA (France) Medical SpecialtiesHealth Technology Manufactures medical implants and single-use medical instruments for spinal surgery | Health Technology |
Theranexus SA
Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases | Health Technology |
- Stock Market
- Insiders
- Thierry Bertrand Lambert
















